Stockreport

Soliton to Announce Cellulite Trial Data for 26-Week Period on July 15, 2019

Soliton, Inc.  (SOLY) 
PDF HOUSTON, July 8, 2019 /PRNewswire/ -- Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technolo [Read more]